GlassScriptPhysician profile
Abhijit Marathe
NPI 1861029647
$3,164.70
in general payments reported to CMS, 2019-2025
8 companies · $1,188 in 2025
The $1,188 reported for 2025 was more than what 90% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $570 · 2024: $1,406 · 2025: $1,188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,065 · Education: $99.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,064.75 |
| Education | $99.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,683.65 | 2023-2025 | Fasenra, Tezspire, Breztri |
| Regeneron Healthcare Solutions, INC. | $425.71 | 2024-2025 | Dupixent |
| Genzyme Corporation | $304.39 | 2023-2025 | |
| Glaxosmithkline, LLC. | $248.41 | 2023-2024 | Nucala, Arexvy |
| Grifols USA, LLC | $150.03 | 2023-2024 | Prolastin-C Liquid, Xembify |
| Boehringer Ingelheim Pharmaceuticals, INC. | $138.99 | 2023-2024 | Ofev |
| Amgen INC. | $113.57 | 2023-2024 | Tezspire |
| Sanofi-Aventis U.S. LLC | $99.95 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abhijit Marathe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.